SCHEDULE: Funicular Funds Reports 7.4% Stake in Pasithea Therapeutics

Funicular Funds, LP, along with affiliated entities Cable Car Capital, LP and Jacob Ma-Weaver, has disclosed beneficial ownership of 1,839,512 shares, representing 7.4% of Pasithea Therapeutics Corp.'s common stock.

Summary

• Funicular Funds, LP, Cable Car Capital, LP, and Jacob Ma-Weaver have jointly filed a Schedule 13G, indicating their beneficial ownership of Pasithea Therapeutics Corp. common stock.
• The total number of shares beneficially owned by these entities is 1,839,512.
• This ownership stake represents 7.4% of the total outstanding shares of Pasithea Therapeutics Corp.
• The calculation of the percentage is based on 24,939,948 shares outstanding, as reported by the Issuer on its Form 10-K filed on March 30, 2026.
• Funicular Funds, LP and Cable Car Capital, LP are organized in Delaware, while Jacob Ma-Weaver is a U.S. citizen.
• Cable Car Capital, LP acts as the General Partner of Funicular Funds, LP, and Jacob Ma-Weaver is the Managing Member of Cable Car Capital, LP, leading to shared beneficial ownership attribution.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It's a standard disclosure of a significant investment position without immediate implications for company operations or performance.

Positives

• Significant ownership stake of 7.4% established by Funicular Funds, LP and its affiliates in Pasithea Therapeutics Corp.
• Clear disclosure of beneficial ownership, providing transparency to the market.

Risks

• Potential for increased scrutiny from regulatory bodies due to the significant ownership stake.
• The filing does not provide details on the purpose of the ownership, which could imply intentions to influence control or engage in activist strategies, though the certification denies this.

Future Outlook

The filing itself is a disclosure of current ownership and does not contain forward-looking statements or guidance regarding the company's future performance or the reporting persons' future investment strategy.

Management Comments

• "The reporting person's beneficial ownership consists of 1,839,512 shares of Common Stock (the "Shares")."
• "The foregoing calculation is based upon 24,939,948 Shares outstanding as reported by the Issuer on Form 10-K filed with the Securities and Exchange Commission on March 30, 2026."
• "Cable Car Capital, LP, as the General Partner of Funicular Funds, LP, and Jacob Ma-Weaver, as the Managing Member of Cable Car Capital, LP, may each be deemed the beneficial owner of the Shares held by Funicular Funds, LP."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and investment funds accumulating significant stakes in publicly traded companies. This filing indicates Funicular Funds, LP and its affiliates have taken a notable position in Pasithea Therapeutics Corp., which could signal confidence or a strategic investment thesis.

Stakeholder Impact

• Shareholders: May view the increased institutional ownership positively, potentially leading to greater market interest or activist engagement, or neutrally as a standard investment disclosure.
• Management: May need to engage with or consider the interests of a significant new shareholder.
• Creditors: Unlikely to be directly impacted by this ownership disclosure.

Next Steps

• Monitoring future filings from Funicular Funds, LP, Cable Car Capital, LP, and Jacob Ma-Weaver for any changes in their stake in Pasithea Therapeutics Corp.
• Observing Pasithea Therapeutics Corp.'s strategic decisions and performance in light of this significant shareholder.

Key Dates

Keywords

Pasithea Therapeutics Corp., Schedule 13G, Funicular Funds, LP, Cable Car Capital, LP, Jacob Ma-Weaver, Beneficial Ownership, Common Stock, SEC Filing, Investment